Literature DB >> 20348558

A model for medication safety event detection.

Rita A Snyder1, Willa Fields.   

Abstract

BACKGROUND: Hospital medication safety event detection predominantly emphasizes the identification of preventable adverse drug events (ADEs) through self-reports. These relatively rare events only provide insight into patient harm and self-reports identify only a small portion of ADEs. A broader system-focused approach to medication safety event detection that uses an array of event detection methods is recommended. This approach illuminates medication system deficits and supports improvement strategies that can prevent future patient risk.
OBJECTIVE: To: (i) describe a system-focused approach to hospital medication safety event detection, and (ii) present a case illustration of approach application. SYSTEM-FOCUSED MODEL AND
METHODOLOGY: A three-level medication safety event detection model that ranges from a narrow harm-focused to broader system-focused approach is described. A standardized cross-level methodology to detect medication safety events is presented. CASE ILLUSTRATION: A Level 3 system-focused methodology that incorporated both voluntary and non-voluntary event detection strategies was used in 17 critical care (n = 4), intermediate care (n = 7) and medical-surgical units (n = 6) across two hospitals. A total of 431 events were detected: 78 (18.1%) ADEs and 353 (81.9%) potential ADEs. Of the 353 PADEs, 302 (70.0%) were non-intercepted events. Non-voluntary detection methods yielded the majority of events (367, 85.1%).
CONCLUSIONS: The incidence of ADEs was low when compared with non-intercepted PADEs. This was indicative of medication safety system failures that placed patients at risk for potential harm. Non-voluntary detection methods were much more effective at detecting events than traditional self-report methods.

Entities:  

Mesh:

Year:  2010        PMID: 20348558      PMCID: PMC2912034          DOI: 10.1093/intqhc/mzq014

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  18 in total

1.  Understanding and responding to adverse events.

Authors:  Charles Vincent
Journal:  N Engl J Med       Date:  2003-03-13       Impact factor: 91.245

2.  Focusing on the preventability of adverse drug reactions.

Authors:  G T Schumock; J P Thornton
Journal:  Hosp Pharm       Date:  1992-06

3.  Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report.

Authors:  A K Jha; G J Kuperman; J M Teich; L Leape; B Shea; E Rittenberg; E Burdick; D L Seger; M Vander Vliet; D W Bates
Journal:  J Am Med Inform Assoc       Date:  1998 May-Jun       Impact factor: 4.497

4.  Drugs--remarkably nontoxic.

Authors:  H Jick
Journal:  N Engl J Med       Date:  1974-10-17       Impact factor: 91.245

5.  Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.

Authors:  D W Bates; D J Cullen; N Laird; L A Petersen; S D Small; D Servi; G Laffel; B J Sweitzer; B F Shea; R Hallisey
Journal:  JAMA       Date:  1995-07-05       Impact factor: 56.272

6.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

7.  The impact of computerized physician order entry on medication error prevention.

Authors:  D W Bates; J M Teich; J Lee; D Seger; G J Kuperman; N Ma'Luf; D Boyle; L Leape
Journal:  J Am Med Inform Assoc       Date:  1999 Jul-Aug       Impact factor: 4.497

8.  Adverse drug event trigger tool: a practical methodology for measuring medication related harm.

Authors:  J D Rozich; C R Haraden; R K Resar
Journal:  Qual Saf Health Care       Date:  2003-06

9.  Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I.

Authors:  T A Brennan; L L Leape; N M Laird; L Hebert; A R Localio; A G Lawthers; J P Newhouse; P C Weiler; H H Hiatt
Journal:  N Engl J Med       Date:  1991-02-07       Impact factor: 91.245

10.  Systems analysis of adverse drug events. ADE Prevention Study Group.

Authors:  L L Leape; D W Bates; D J Cullen; J Cooper; H J Demonaco; T Gallivan; R Hallisey; J Ives; N Laird; G Laffel
Journal:  JAMA       Date:  1995-07-05       Impact factor: 56.272

View more
  3 in total

1.  Medication errors in pediatric inpatients: a study based on a national mandatory reporting system.

Authors:  Rikke Mie Rishoej; Anna Birna Almarsdóttir; Henrik Thybo Christesen; Jesper Hallas; Lene Juel Kjeldsen
Journal:  Eur J Pediatr       Date:  2017-10-01       Impact factor: 3.183

2.  Potential adverse drug events and its predictors among hospitalized patients at medical center in Ethiopia: a prospective observational study.

Authors:  Tamiru Sahilu; Mestawet Getachew; Tsegaye Melaku; Tadesse Sheleme; Duresa Abu; Tesfu Zewdu
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

3.  Adverse Drug Events and Contributing Factors Among Hospitalized Adult Patients at Jimma Medical Center, Southwest Ethiopia: A Prospective Observational Study.

Authors:  Tamiru Sahilu; Mestawet Getachew; Tsegaye Melaku; Tadesse Sheleme
Journal:  Curr Ther Res Clin Exp       Date:  2020-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.